Primaa
AI-based cancer diagnostics software
- B2B
- SaaS
- AI-native
About Primaa
The company develops AI software for automated, accurate histological and cancer diagnoses, leveraging advanced technology to improve healthcare outcomes
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- paris, ile-de-france, France
- Revenue
- $8.1M – $64.2MTamtam estimate
- Website
- primaalab.com
- linkedin.com/company/primaa
Primaa in the news
- Primaa Secures €7 Million in Funding
Primaa secured €7 million to expand its AI-based cancer diagnostic software across Europe and prepare for U.S. market entry.
- Primaa, l’intelligence artificielle qui assiste les médecins dans le diagnostic des cancers
Primaa's AI software Cleo assists pathologists in rapidly and accurately diagnosing cancers, reducing wait times and improving patient care without replacing doctors.
- Comment l’intelligence artificielle transforme le diagnostic anatomopathologique
AI is enhancing cancer diagnosis by automating tissue image analysis, with Primaa developing software to detect breast and skin cancers and recently securing funding to expand and enter the US market.
- Primaa raises €7M to accelerate product growth and international expansion
Primaa secured €7M to expand its AI-based cancer diagnostic tools across Europe and the US, enhancing product features and sales.
- Primaa raises €7M to advance AI cancer diagnostics
Primaa secured €7M to expand its AI-powered cancer diagnostic tools and accelerate European and US market growth.
Primaa at a glance
Primaa is a B2B SaaS company in the Biotechnology Research industry, headquartered in paris, ile-de-france, France.
Primaa has 11–50 employees.
Primaa's revenue is $8.1M – $64.2M (Tamtam estimate).
Selling to companies like Primaa?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies